Amneal Pharmaceuticals, Inc.
AMRX· Nasdaq
AMRXAmneal Pharmaceuticals, Inc.
Filed Nov 7, 2019 · 10-Q · 38 days after period end · 0001564590-19-041240
| Metric | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|
| Revenue | $378.28M | $476.49M | $254.73M |
| Net Income | -$265.01M | $6.89M | $0.00 |
| EPS Diluted | -$2.03 | $0.05 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 7, 2019 · 38 d after period end
